Analysts coverage & consensus
In an effort to increase the transparency towards the financial community, Syensqo Investor Relations collects and shares the most recent analysts’ estimates.
All data are on underlying basis unless stated otherwise. Units: € million / %
| Companies | Lead Analyst | Recommendation | Target Price | ||
| ABN ODDO | Stefano Toffano | Hold | 78 | ||
| Barclays | Alex Stewart | Hold | 86 | ||
| Berenberg | Aron Ceccarelli | Hold | 76 | ||
| Bernstein | James Hooper | Buy | 80 | ||
| BOFA | Matthew Yates | Hold | 70 | ||
| Citi | Ranulf Orr | Hold | 62 | ||
| Degroof Petercam | Frank Claassen | Buy | 86 | ||
| Deutsche Bank | Tristan Lamotte | Buy | 82 | ||
| Equita | Massimo Bonisoli | Buy | 80 | ||
| BNP Exane | Laurent Favre | Buy | 88 | ||
| ING | Stijn Demeester | Buy | 95 | ||
| JP Morgan | Chetan Udeshi | Buy | 90 | ||
| Jefferies | Chris Counihan | Buy | 80 | ||
| KBC | Wim Hoste | Buy | 90 | ||
| Kepler Cheuvreux | Martin Rödiger | Buy | 88 | ||
| Morgan Stanley | Jonathan Chung | Buy | 88 | ||
| UBS | Geoff Haire | Buy | 90 | ||
| Van Lanschot Kempen | Jeremy Kincaid | Hold | 70 | ||
| Recommendation | Target price | |||
| Buy | 12 | Average | 82 | ||
| Hold | 6 | Max | 95 | ||
| Sell | 0 | Min | 62 | ||
Units: € million / % | LOW | AVERAGE | HIGH | #ESTS |
GROUP SALES | 1,624 | 1,659 | 1,690 | 8 |
| Materials | 910 | 937 | 959 | 8 |
| Specialty Polymers | 597 | 620 | 645 | 7 |
| Composite Materials | 309 | 320 | 333 | 7 |
| Perfomance & Care | 524 | 539 | 552 | 7 |
| Novecare | 343 | 355 | 365 | 7 |
| Technology Solutions | 171 | 184 | 197 | 7 |
| Other Solutions | 174 | 180 | 188 | 7 |
| Aroma | 73 | 77 | 83 | 7 |
| Oil & Gas | 93 | 102 | 108 | 7 |
GROSS PROFIT | 505 | 540 | 582 | 5 |
| Gross Margin | 30.2% | 32.7% | 35.0% | 6 |
GROUP UNDERLYING EBITDA | 335 | 340 | 349 | 9 |
| Group EBITDA Margin | 20.2% | 20.5% | 21.1% | 9 |
| Materials | 262 | 270 | 278 | 9 |
| EBITDA Margin | 27.6% | 28.8% | 29.3% | 9 |
| Performance & Care | 99 | 105 | 112 | 7 |
| EBITDA Margin | 18.5% | 19.3% | 20.7% | 7 |
| Other Solutions | 8 | 15 | 21 | 7 |
| EBITDA Margin | 4.6% | 8.7% | 11.7% | 7 |
| Corporate | -60 | -51 | -42 | 9 |
CAPEX | -159 | -145 | -126 | 5 |
FCF TO SHAREHOLDERS | n.a. | n.a. | n.a. | n.a. |
Units: € million / % | LOW | AVERAGE | HIGH | #ESTS |
GROUP SALES | 6,383 | 6,482 | 6,581 | 9 |
| Materials | 3,596 | 3,653 | 3,733 | 9 |
| Specialty Polymers | 2,345 | 2,385 | 2,435 | 7 |
| Composite Materials | 1,226 | 1,257 | 1,277 | 7 |
| Performance & Care | 2,070 | 2,113 | 2,149 | 8 |
| Novecare | 1,387 | 1,416 | 1,454 | 7 |
| Technology Solutions | 668 | 699 | 748 | 7 |
| Other Solutions | 687 | 710 | 750 | 8 |
| Aroma | 289 | 301 | 312 | 7 |
| Oil & Gas | 365 | 401 | 418 | 7 |
GROSS PROFIT | 1,996 | 2,115 | 2,288 | 5 |
| Gross Margin | 30.8% | 32.8% | 35.0% | 5 |
GROUP UNDERLYING EBITDA | 1,311 | 1,339 | 1,355 | 9 |
| Group EBITDA Margin | 20.2% | 20.7% | 21.0% | 9 |
| Materials | 1,043 | 1,079 | 1,104 | 9 |
| EBITDA Margin | 28.7% | 29.5% | 30.2% | 9 |
| Perfomance & Care | 395 | 408 | 421 | 7 |
| EBITDA Margin | 18.6% | 19.4% | 19.9% | 7 |
| Other Solutions | 49 | 60 | 71 | 7 |
| EBITDA Margin | 6.9% | 8.4% | 10.0% | 7 |
| Corporate | -226 | -206 | -198 | 9 |
CAPEX | -617 | -600 | -587 | 6 |
FCF TO SHAREHOLDERS EXCL. NJDEP SETTLEMENT | n.a. | n.a. | n.a. | n.a. |
(1) Cash conversion of last 12 months = (underlying EBITDA +/- Changes in Working Capital - Sustenance Capital Expenditure) / (underlying EBITDA)
(2) Underlying leverage = Underlying net debt / underlying EBITDA of last 12 months
(3) Gearing = Gearing : Underlying net debt / (underlying net debt + equity)
(4) ROCE: Return on Capital employed, calculated as the ratio between underlying EBIT (before adjustment for the amortization of PPA) and capital employed. Capital employed consists of net working capital, tangible and intangible assets, goodwill, rights-of-use assets, investments in associates & joint ventures and other investments, and is taken as the average of the situation at the end of the last 12 months